BUNGE GLOBAL SA
BGNYSE🏆 #555 by market capEarnings Nov 3 · PreUS Equity
$108.14▼ $0.91 (−0.84%)
🌙 After hours$108.20▲ 0.06%Regular close · extended-hours price shownTrack BG
Get earnings, price moves & breaking news on Telegram
24h▼ 0.8%
7d▼ 2.5%
14d▼ 11.2%
30d▼ 6.3%
ytd▲ 21.3%
1y▲ 31.2%
🏦Market Cap
$20.78B
Mid Cap
📈Revenue Growth (YoY)
+80.5%
High Growth
📊Gross Margin
4.9%
Thin
💵FCF Margin
1.3%
Thin
⚖️P/S Ratio
0.2x
Cheap
Otter Score
76
Good
BUNGE GLOBAL SA
BGAnalyst Ratings
Price
$108.14
Total
25
Raised
7
Lowered
2
Avg PT
$151.67
H / L
$155 / $150
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-09-10 | $155.00 | +43.30% |
Barclays | Reiterated | Overweight | 2026-04-30 | $150.00 | +38.70% |
JP Morgan | Reiterated | Overweight | 2026-03-24 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-03-11 | $130.00 | +20.20% |
BMO Capital | Reiterated | Outperform | 2026-03-11 | $150.00 | +38.70% |
B of A Securities | Reiterated | Buy | 2025-12-02 | — | — |
Stephens & Co. | Reiterated | Overweight | 2025-10-17 | — | — |
Citigroup | Reiterated | Neutral | 2025-04-15 | — | — |
Goldman Sachs | Reiterated | Buy | 2024-02-13 | — | — |
HSBC | Upgraded | Hold → Buy | 2024-02-09 | $105.00 | −2.90% |
Roth MKM | Reiterated | Buy | 2024-02-05 | — | — |
Baird | Reiterated | Neutral | 2024-01-23 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2024-01-10 | — | — |
Credit Suisse | Reiterated | Outperform | 2022-06-23 | $140.00 | +29.50% |
Bank of America | Upgraded | Neutral → Buy | 2016-08-02 | — | — |
BB&T Capital | Reiterated | Buy | 2016-07-12 | — | — |
Macquarie | Reiterated | Outperform | 2015-10-29 | — | — |
Vertical Research | Reiterated | Buy | 2015-07-07 | — | — |
Feltl & Co. | Upgraded | Hold → Buy | 2013-10-23 | — | — |
Miller Tabak | Downgraded | Buy → Hold | 2013-10-21 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2013-06-12 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2013-06-11 | — | — |
Topeka | Upgraded | Hold → Buy | 2012-07-30 | — | — |
Topeka Capital | Upgraded | Hold → Buy | 2012-07-29 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2012-04-29 | — | — |
Institution
UBS
Reiterated · Buy · 2026-09-10
$155.00
+43.30%
Barclays
Reiterated · Overweight · 2026-04-30
$150.00
+38.70%
JP Morgan
Reiterated · Overweight · 2026-03-24
—
—
Morgan Stanley
Reiterated · Overweight · 2026-03-11
$130.00
+20.20%
BMO Capital
Reiterated · Outperform · 2026-03-11
$150.00
+38.70%
B of A Securities
Reiterated · Buy · 2025-12-02
—
—
Stephens & Co.
Reiterated · Overweight · 2025-10-17
—
—
Citigroup
Reiterated · Neutral · 2025-04-15
—
—
Goldman Sachs
Reiterated · Buy · 2024-02-13
—
—
HSBC
Upgraded · Hold → Buy · 2024-02-09
$105.00
−2.90%
Roth MKM
Reiterated · Buy · 2024-02-05
—
—
Baird
Reiterated · Neutral · 2024-01-23
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2024-01-10
—
—
Credit Suisse
Reiterated · Outperform · 2022-06-23
$140.00
+29.50%
Bank of America
Upgraded · Neutral → Buy · 2016-08-02
—
—
BB&T Capital
Reiterated · Buy · 2016-07-12
—
—
Macquarie
Reiterated · Outperform · 2015-10-29
—
—
Vertical Research
Reiterated · Buy · 2015-07-07
—
—
Feltl & Co.
Upgraded · Hold → Buy · 2013-10-23
—
—
Miller Tabak
Downgraded · Buy → Hold · 2013-10-21
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2013-06-12
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2013-06-11
—
—
Topeka
Upgraded · Hold → Buy · 2012-07-30
—
—
Topeka Capital
Upgraded · Hold → Buy · 2012-07-29
—
—
Scotiabank
Reiterated · Sector Outperform · 2012-04-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space